Budesonide (inhalation suspension): study card

Generic name

Budesonide (inhalation suspension)

Class

Inhaled corticosteroid (ICS)

Mechanism

Anti-inflammatory corticosteroid with potent glucocorticoid and weak mineralocorticoid activity.

Used for

Asthma maintenance and prevention in children aged 12 months to 8 years, for the cited inhalation suspension

Common side effects

Respiratory infection; Rhinitis; Coughing; Otitis media; Viral infection

Warnings

Oral Candida infection; Not for acute bronchospasm; Immunosuppression; adrenal suppression

Interactions

Strong CYP3A4 inhibitors (e.g., ritonavir)

Brand questions use only name pairings verified against the linked product source. Unverified pairings are withheld from these questions; the other study content remains available.

Label date: 20260716 · For learning, not clinical decisions. US label and brand information; always consult the current source.

Source snapshot checked: 2026-10-21. The source document and selected fields were compared. The complete card has not had an independent clinical review.